LEADER 04393nam 22005775 450 001 9910369950003321 005 20200706223223.0 010 $a3-030-18396-3 024 7 $a10.1007/978-3-030-18396-7 035 $a(CKB)4100000008959097 035 $a(MiAaPQ)EBC5850220 035 $a(DE-He213)978-3-030-18396-7 035 $a(PPN)269144684 035 $a(EXLCZ)994100000008959097 100 $a20190812d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNeuroblastoma $eClinical and Surgical Management /$fedited by Sabine Sarnacki, Luca Pio 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (viii, 383 pages) 311 $a3-030-18395-5 327 $aChapter 1. Epidemiology -- Chapter 2. Biology of neuroblastoma -- Chapter 3. Neuroblastoma pathogenesis -- Chapter 4. Neuroblastoma Pathology -- Chapter 5. Radiology -- Chapter 6. Image Defined Risk Factors -- Chapter 7. Nuclear Medicine procedures in Neuroblastoma -- Chapter 8. Radiotherapy for neuroblastoma -- Chapter 9. Spinal canal involvement in peripheral neuroblastic tumors -- Chapter 10. Neonatal Neuroblastoma -- Chapter 11. Low and intermediate risk Neuroblastoma -- Chapter 12. High risk Neuroblastoma and current Protocols -- Chapter 13. Immunotherapy -- Chapter 14. Prognostic Factors and Risk Stratification -- Chapter 15. BIOPSY OF NEUROBLASTOMA -- Chapter 16. Surgical Techniques -- Chapter 17. Surgical strategies for high risk neuroblastoma -- Chapter 18. Surgical strategies for Neuroblastoma with spinal canal involvement -- Chapter 19. Neuroblastoma ? Minimally invasive surgery -- Chapter 20. Robotic Surgery for Neuroblastoma -- Chapter 21. Complications of the surgical management of children with neuroblastoma -- Chapter 22. Palliative Care. 330 $aThis book addresses neuroblastoma, a type of embryonic tumor derived from neural crest cells and one of the most frequent extra-cranial solid tumors in children. However, the term also describes a heterogeneous group of tumors, the prognosis of which can differ greatly according to age, stage and biology. Some forms undergo spontaneous regression, and some are cured by surgery alone or after chemo-reduction, while others exhibit extremely aggressive behavior. Their successful treatment is one of the best examples of tailored medicine, which involves close collaboration between pediatric surgeons, pediatric oncologists, radiologists, nuclear medicine specialists, biologists, oncogeneticists and radiotherapists. The book pursues a unique approach, as it combines most essential insights from all of these fields, together with key information regarding epidemiology, physiopathology and palliative care. The respective chapters were written by the leading international experts on neuroblastoma, and present the latest advances in terms of research, surgical approaches and medical treatments. The book offers an invaluable resource to all pediatric surgeons, pediatricians, oncologists, students, researchers and all others involved in neuroblastoma management who want to benefit from their colleagues? expertise. 606 $aPediatric surgery 606 $aPediatrics 606 $aOncology   606 $aSurgical oncology 606 $aPediatric Surgery$3https://scigraph.springernature.com/ontologies/product-market-codes/H59079 606 $aPediatrics$3https://scigraph.springernature.com/ontologies/product-market-codes/H49006 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aSurgical Oncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H59150 615 0$aPediatric surgery. 615 0$aPediatrics. 615 0$aOncology  . 615 0$aSurgical oncology. 615 14$aPediatric Surgery. 615 24$aPediatrics. 615 24$aOncology. 615 24$aSurgical Oncology. 676 $a617.98 676 $a616.99383 702 $aSarnacki$b Sabine$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPio$b Luca$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910369950003321 996 $aNeuroblastoma$92111774 997 $aUNINA